PWRM, - Stem Cell Biotechnology - Protein Biomarkers could be an Explosive Combination for its Trading Levels - DrStockPick.com Watch List! for Monday May 10, 2010
Dr Stock Pick HOT News & Alerts!
FREE Daily Stock Alerts From DrStockPick.com
DrStockPick.com Watch List!
My Pick for Monday May 10, 2010 is:
*******************
PWRM, Power 3 Medical Products Inc., PWRM.OB
More on PWRM
Stem cells are distinguished from other cell types by two important characteristics. First, they are unspecialized cells capable of renewing themselves through cell division, sometimes after long periods of inactivity. Second, under certain physiologic or experimental conditions, they can be induced to become tissue- or organ-specific cells with special functions. In some organs, such as the gut and bone marrow, stem cells regularly divide to repair and replace worn out or damaged tissues. In other organs, however, such as the pancreas and the heart, stem cells only divide under special conditions.
Stem cell research is one of the most fascinating areas of contemporary biology, but, as with many expanding fields of scientific inquiry, research on stem cells raises scientific questions as rapidly as it generates new discoveries.
Results from a first stage trial with Parkinson’s patients provides additional promise for patients suffering from Alzheimer’s, clinical trials are expected to begin within the next several months.
If as we believe Stem Cells will be the panacea it is expected to be, the biomarkers developed by PWRM could become very valuable tools in the fight to find a cure, by providing the earliest onset of Alzheimer’s, even before the symptoms have become pronounced.
Just take a look at PWRM’s 5 day chart

PWRM’s chart speaks by itself!!
Let us remind you that recently, a joint provisional patent application entitled, “Stem Cell Protein Biomarkers and Their Use in Monitoring Stem Cells and Their Products for Stem Cell Therapy” has been filed by the principals of StemTroniX and PWRM with the United States Patent and Trademark Office.
The provisional patent application discloses technologies designed to enhance the therapeutic process capabilities through the identification of the patients’ own stem cells. This patent application will be assigned by the inventors to the surviving public entity, to be named “StemTroniX,” upon the closing of the acquisition of StemTroniX by PWRM (in February 2010, PWRM entered into a definitive merger agreement to acquire StemTroniX, Inc., a stem cell biotechnology acquisition and holding company that is committed to improving the lives of individuals by using autologous adult stem cell technology to repair tissue damage in patients).
Keep a close eye on PWRM from now on!!
PWRM is trading around $0.07 cents.
There is still time to include PWRM to your watch list!!
The combination Stem Cell Biotechnology - Protein Biomarkers could be explosive for PWRM’s trading levels and you don’t want to be out of the action!!
More about PWRM at www.power3medical.com.
**************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com End Of day publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick Stock Watch report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) . Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB).
Tags: breast cancer, Parkinson’s disease, Power 3 Medical Products, PWRM, PWRM.OB, Stem Cells, StemCells, StemTroniX
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|








